Tobramycin for Injection recall — Class II (D-0385-2024) · pharmaranks
Class IITerminated
Tobramycin for Injection recall
FDA recall D-0385-2024 · initiated Feb 22, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed Stability Specification: Water determination was found not complying with specification.
Details
Product
Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.